This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
In an interview, Cherokee Layson-Wolf, PharmD, BCACP, FAPhA, professor of practice, sciences, and health outcomes research at the University of Maryland, explored the evolving landscape of vaccine recommendations, emphasizing the critical role pharmacists play in guiding patients through complex medical information.
In an interview on vaccine recommendations, health care professionals expressed growing concerns about the changing landscape of medical information dissemination. Health care professionals emphasize patient education and reliable information in the evolving vaccine recommendation landscape.
In 2022, the Advisory Committee on Immunization Practices (ACIP) published updated pneumococcal vaccine recommendations. In 2022, the Advisory Committee on Immunization Practices (ACIP) published updated pneumococcal vaccine recommendations.
Experts discuss the recent dismissal of all 17 members of the Advisory Committee on Immunization Practices (ACIP), a panel that provides guidance to the CDC on vaccine recommendations. This abrupt change has raised significant concerns within the health care community about the potential impact on vaccine trust and public health policy.
Garofoli, PharmD, BCACP, CTTS, FAPhA Publication Article Drug Topics Journal Drug Topics May/June 2025 Volume 169 Issue 03 Pharmacy team members can help patients prepare for upcoming travels, ensuring they are up to date with the recommended vaccines for their locations. The first resource is the CDC’s Yellow Book.
FDA Approves Mepolizumab for Treatment of COPD Exacerbations Brian Nowosielski May 22nd 2025 Article Approval comes from positive results in the MATINEE and METREX phase III trials, with data showing a significant reduction in annual rates of COPD exacerbations among patients.
With significant progress made in researchers’ understanding of dermatological diseases, a pathway has been made for the development of targeted vaccines, according to data published in Vaccines. 5 Throughout the past 10 years, development of vaccines for preventing skin diseases has made significant progress.
Rite Aid, which was once the third largest pharmacy chain in the United States, announced in May that it filed its second chapter 11 bankruptcy in under 2 years. Drug Topics : How has the closure of Rite Aid stores impacted independentpharmacies in Pennsylvania? Rob Frankil, RPh : I'm seeing a mixed bag.
In a vote of 5 to 1 on Thursday, members of the Advisory Committee on Immunization Practices (ACIP) voted to recommend against influenza vaccine containing the preservative thimerosal. The recommendations include all US adults as well as recommending pregnant women also receive a thimerosal-free vaccine for influenza.
Pharmacy Technicians Could Enhance Public Health by Becoming ‘Vaccine Champions’ Killian Meara October 3rd 2024 Article Researchers suggest that vaccine champion programs could be a promising avenue to increasing immunization rates.
McKesson ideaShare 2025 brought thousands of independent pharmacists, pharmacy owners, technicians, and industry leaders together in Nashville, Tennessee, shining a spotlight on innovation and advocacy in community pharmacy.
Because technicians often understand daily pharmacy operations more intimately than pharmacists, they should be involved in decisions related to workflow, technology, and design. Many independentpharmacies already do this well, but larger chains need to catch up.
Strategies for IndependentPharmacies to Harness Consumer Trends and Meet the Competition Peter Koo, PharmD May 19th 2025 Article Pharmacies face mounting challenges amid increased competition, rising operational costs, and complex reimbursement models. 2013;3(4):e002361. 2013;3(4):e002361.
News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy (..)
Vaccine Coverage Remains Low Among Forcibly Displaced Children Brian Nowosielski June 17th 2025 Article Researchers conducted a systematic review and meta-analysis to estimate vaccine coverage and identify factors associated with vaccination among forcibly displaced, pediatric populations.
Related Content Pharmacy Technicians Could Enhance Public Health by Becoming ‘Vaccine Champions’ Killian Meara October 3rd 2024 Article Researchers suggest that vaccine champion programs could be a promising avenue to increasing immunization rates. J Am Pharm Assoc (2003). 2025 May 9:102419. doi: 10.1016/j.japh.2025.102419.
News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)
Kevin Cleveland, PharmD, professor at Idaho State University, explores the potential impacts of changes to the Advisory Committee on Immunization Practices (ACIP), highlighting concerns about shifting medical guidance and vaccine recommendations. Cleveland: So I'll start as a provider.
The software integrates directly with existing pharmacy management systems and features adherence monitoring, vaccine registry integration, performance measure tracking, an administrative assistant powered by AI, and more.
The FDA has approved sebetralstat (Ekterly) for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients 12 years of age or older, according to a release from KalVista Pharmaceuticals. 1 The decision makes sebetralstat the first and only oral on demand treatment option for the condition. References 1.
Ensuring patients are current on MMR vaccines is crucial due to global measles outbreaks, with specific recommendations for international travelers. SHOW MORE As summer heats up, pharmacists can provide travel vaccines and other recommendations.
Q&A: Prioritizing Pharmacy Technician Well-Being Killian Meara ; Taylor Watterson, PharmD, PhD June 20th 2025 Article Taylor Watterson, PharmD, PhD, discusses the primary contributors to stress or frustration among pharmacy technicians and how to fix them.
Harvard Poll Shows 1 in 5 Adults Do Not Support Routine Childhood Vaccine Requirements Ashley Gallagher June 30th 2025 Article Of those who do not support vaccines, 79% said a major reason for their opposition is that it should be the parents’ choice about whether to vaccinate their child and 40% cite safety concerns.
link] Recent Videos Related Content Q&A: Expert Highlights Importance of Trusted Sources for Vaccine Information Ashley Gallagher ; Laura Knockel, PharmD, BCACP July 6th 2025 Article Health care professionals emphasize patient education and reliable information in the evolving vaccine recommendation landscape.
The FDA has approved lenacapavir (Yeztugo) as pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV in adult and adolescent patients weighing at least 35kg, Gilead Sciences announced in a release. READ MORE: HIV Resource Center Pharmacy practice is always changing.
The FDA approved clesrovimab-cfor (Enflonsia) for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in newborns and infants born during or entering their first RSV season, Merck announced in a release. References 1.
But that’s setting yourself up for frustrationespecially when outside factors (DIR fees, staffing shortages, FDA, etc.) For example, if your goal is to grow your immunization program, don’t just say, “I want to do more vaccines.” ” Instead, set three tiers: Good: Administer 500 vaccines in 2025. .”
Interchangeable designation allows substitution at pharmacies, potentially increasing market competition and reducing insulin costs. The FDA approved insulin aspart-xjhz (Kirsty; Biocon Sdn. The product is a rapid-acting human insulin analog, available in prefilled pens and vials, offering administration flexibility.
21 / stock.adobe.com READ MORE: Progress in Dermatology Paves the Way for Vaccine Development While essential for the treatment of skin conditions like AD, each variation of TCSs is classified by its strength and risk of adverse effects. image credit: jittawit.21
The FDA has accepted for review a New Drug Application (NDA) for doravirine/islatravir for adult patients with HIV-1 infection that is virologically suppressed on antiretroviral therapy, Merck announced in a release. 1 The FDA set a Prescription Drug User Fee Act (PDUFA) date of April 28, 2026. References 1. Subscribe Now!
SHOW MORE FDA approves a new dosing schedule for donanemab, enhancing safety and efficacy in treating early symptomatic Alzheimer disease. This advancement provides healthcare professionals with improved confidence in managing Alzheimer's disease with donanemab.
We look forward to engaging with the FDA and expanding on these results in our planned phase 3 trial." Cidara Therapeutics Announces Positive Topline Results from its Phase 2b NAVIGATE Trial Evaluating CD388, a Non-Vaccine Preventative of Seasonal Influenza. Sign up today for our free Drug Topics newsletter. References 1.
The FDA approved a label expansion for glecaprevir/pibrentasvir (Mavyret) to treat acute hepatitis C virus (HCV) infection in patients 3 years of age and older with compensated cirrhosis or without cirrhosis, AbbVie announced in a release. 3 READ MORE: Infectious Disease Resource Center Pharmacy practice is always changing.
She admitted she was using them for injection drug use, and I gave her 5 syringes we were using for COVID-19 vaccine injections that were provided by the government. She was most grateful and assured me she was going to seek help the next day.
In a new CDC report, investigators found that there was no connection between thimerosal in vaccines and autism or other neurodevelopmental conditions. The properties of thimerosal were documented to contribute to the safe use of multidose vials and packaging of vaccines, such as seasonal and pandemic influenza vaccines.
The FDA approved belimumab (Benlysta), a 200 mg/mL autoinjection, for subcutaneous injection in patients 5 years of age and older with active lupus nephritis who are receiving standard therapy. FDA approves Benlysta (belimumab) Autoinjector for children with active lupus nephritis. Sign up today for our free Drug Topics newsletter.
Investigators found that incorporating either the pneumococcal conjugate vaccine (PCV) 20 or PCV 15 and the 23-valent pneumococcal polysaccharide vaccine (PPSV23) had an incremental budget impact of $6.5 2,3 In June 2024, the ACIP announced updates to the vaccine schedule to prevent invasive pneumococcal disease.
Measles Outbreak Reaches Over 800 Confirmed Cases in the US Ashley Gallagher June 7th 2025 Article Building trust with patients through fact-based information could help boost vaccination rates to the desirable coverage.
Sweden’s move from the 13-valent pneumococcal conjugate vaccine (PCV13) to PCV10 in 2019 is most likely responsible for the uptick in pHUS cases because of changes in serotype coverage. In the US, recommendations are slightly different, with PCV13 being the safest and most effective pneumococcal vaccine for both children and adults.
Of these cases, 96% were reported in patients who were unvaccinated or had unknown vaccination status. 1 Building trust with patients through fact-based information could help boost vaccination rates to the desirable coverage. After the vaccine became available in 1963, the CDC tried to eliminate measles in the US by 1982.
image credit: Drobot Dean / stock.adobe.com READ MORE: ACIP Votes to Expand RSV Vaccine Recommendation to Include Adults 50 Years and Older Along with older adults over 65, children too are deemed at risk of contracting respiratory illnesses; a risk that was significantly increased during the COVID-19 pandemic.
announced that all current members of the CDC's Advisory Committee for Immunization Practices (ACIP) will be retired and replaced in order to “reestablish public confidence in vaccine science.” 1 “A clean sweep is necessary to reestablish public confidence in vaccine science,” Kennedy said in the release. Kennedy Jr.
Progress in Dermatology Paves the Way for Vaccine Development Brian Nowosielski June 20th 2025 Article Researchers reviewed current understandings of the role vaccines play in dermatology, what gaps persist, and what future research is necessary.
FDA Approves Mepolizumab for Treatment of COPD Exacerbations Brian Nowosielski May 22nd 2025 Article Approval comes from positive results in the MATINEE and METREX phase III trials, with data showing a significant reduction in annual rates of COPD exacerbations among patients.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content